Ugur Sahin
CEO at BioNTech SE (BNTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $84.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 9 NewSEC | BNTXBioNTech SE | Sell Plan | 27,00036,209 held (−43%) | $92.31 | $2.5M | +5.0% |
| Oct 9 NewSEC | BNTXBioNTech SE | Sell Plan | 36,209 | $95.37 | $3.5M | +1.7% |
| Oct 7SEC | BNTXBioNTech SE | Sell Plan | 24,00063,209 held (−28%) | $95.86 | $2.3M | +1.1% |
| Oct 6SEC | BNTXBioNTech SE | Sell Plan | 72,000108,209 held (−40%) | $97.23 | $7.0M | -0.3% |
| Oct 6SEC | BNTXBioNTech SE | Sell Plan | 21,00087,209 held (−19%) | $96.81 | $2.0M | +0.2% |
| Oct 2SEC | BNTXBioNTech SE | Sell Plan | 17,000197,209 held (−8%) | $97.46 | $1.7M | -0.5% |
| Oct 2SEC | BNTXBioNTech SE | Sell Plan | 17,000180,209 held (−9%) | $96.72 | $1.6M | +0.2% |
| Sep 30SEC | BNTXBioNTech SE | Sell Plan | 34,000246,209 held (−12%) | $98.26 | $3.3M | -1.3% |
| Sep 30SEC | BNTXBioNTech SE | Sell Plan | 32,000214,209 held (−13%) | $98.12 | $3.1M | -1.2% |
| Sep 28SEC | BNTXBioNTech SE | Sell Plan | 27,000314,209 held (−8%) | $98.69 | $2.7M | -1.8% |
| Sep 28SEC | BNTXBioNTech SE | Sell Plan | 34,000280,209 held (−11%) | $98.47 | $3.3M | -1.5% |
| Sep 24SEC | BNTXBioNTech SE | Sell Plan | 30,000380,209 held (−7%) | $99.40 | $3.0M | -2.5% |
| Sep 24SEC | BNTXBioNTech SE | Sell Plan | 39,000341,209 held (−10%) | $98.99 | $3.9M | -2.1% |
| Sep 22SEC | BNTXBioNTech SE | Sell Plan | 33,000456,209 held (−7%) | $97.81 | $3.2M | -0.9% |
| Sep 22SEC | BNTXBioNTech SE | Sell Plan | 46,000410,209 held (−10%) | $100.72 | $4.6M | -3.7% |
| Sep 18SEC | BNTXBioNTech SE | Sell Plan | 34,000519,209 held (−6%) | $98.60 | $3.4M | -1.7% |
| Sep 18SEC | BNTXBioNTech SE | Sell Plan | 30,000489,209 held (−6%) | $96.22 | $2.9M | +0.8% |
| Sep 16SEC | BNTXBioNTech SE | Sell Plan | 34,000568,209 held (−6%) | $96.49 | $3.3M | +0.5% |
| Sep 16SEC | BNTXBioNTech SE | Sell Plan | 15,000553,209 held (−3%) | $96.09 | $1.4M | +0.9% |
| Sep 14SEC | BNTXBioNTech SE | Sell Plan | 45,000643,209 held (−7%) | $96.93 | $4.4M | +0.0% |
| Sep 14SEC | BNTXBioNTech SE | Sell Plan | 41,000602,209 held (−6%) | $99.45 | $4.1M | -2.5% |
| Sep 11SEC | BNTXBioNTech SE | Sell Plan | 20,500688,209 held (−3%) | $96.31 | $2.0M | +0.7% |
| Sep 9SEC | BNTXBioNTech SE | Sell Plan | 37,000744,709 held (−5%) | $99.20 | $3.7M | -2.3% |
| Sep 9SEC | BNTXBioNTech SE | Sell Plan | 36,000708,709 held (−5%) | $97.78 | $3.5M | -0.8% |
| Sep 8SEC | BNTXBioNTech SE | Sell Plan | 45,000813,209 held (−5%) | $102.85 | $4.6M | -5.7% |
| Sep 8SEC | BNTXBioNTech SE | Sell Plan | 31,500781,709 held (−4%) | $103.52 | $3.3M | -6.3% |
- Sell
CEO Ugur Sahin sold $2.5M of BNTX at $92.31 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Ugur Sahin sold $3.5M of BNTX at $95.37 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Ugur Sahin sold $2.3M of BNTX at $95.86 — cuts the stake by 28%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Ugur Sahin sold $7.0M of BNTX at $97.23 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Ugur Sahin sold $2.0M of BNTX at $96.81 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Ugur Sahin sold $1.7M of BNTX at $97.46 — pre-scheduled 10b5-1 plan sale.